Table 1 |
|||
|
Demographic and clinical patient characteristics of primary breast carcinomas (n = 150) |
|||
| Variable |
Categorisation |
n1 |
% |
|
|
|||
| Clinicopathological factors |
|||
| Age at diagnosis |
|||
| median: 57 years (range 28 to 86 years) |
|||
| <57 years |
74 |
49.3 |
|
| = 57 years |
76 |
50.7 |
|
| Tumour size2 |
|||
| pT1 |
59 |
39.3 |
|
| pT2 |
70 |
46.7 |
|
| pT3 |
8 |
5.3 |
|
| pT4 |
10 |
6.7 |
|
| pTx |
3 |
2.0 |
|
| Lymph node status2 |
|||
| pN0 |
72 |
48.0 |
|
| pN1 to 3 |
71 |
47.3 |
|
| PNx |
7 |
4.7 |
|
| Histological grade |
|||
| G1 |
13 |
8.7 |
|
| G2 |
75 |
50.0 |
|
| G3 |
62 |
41.3 |
|
| Histological type |
|||
| Ductal |
122 |
81.3 |
|
| Lobular |
19 |
12.7 |
|
| Other |
9 |
6.0 |
|
| Immunohistochemistry |
|||
| Oestrogen receptor |
|||
| Negative (IRS3 0 to -2) |
47 |
31.3 |
|
| Positive (IRS 3 to 12) |
98 |
65.3 |
|
| n.a. |
5 |
3.3 |
|
| Progesterone receptor |
|||
| Negative (IRS3 0 to 2) |
51 |
34.0 |
|
| Positive (IRS 3 to 12) |
94 |
62.7 |
|
| n.a. |
5 |
3.3 |
|
|
|
|||
|
1Only female patients with unilateral invasive breast cancer were included. 2According to International Union Against Cancer: TNM Classification of Malignant Tumours [32].3IRS = immunoreactivity score [35]. n.a. = not available. |
|||
|
Veeck et al. Breast Cancer Research 2008 10:R82 doi:10.1186/bcr2151 |
|||
